Pharma Tries To Nix Shareholder Suit Over Failed Antibiotic
A Massachusetts startup pharmaceutical company on Friday asked a federal judge in Boston to dismiss a class securities suit it's facing over a botched drug approval, calling the claims speculative attempts...To view the full article, register now.
Already a subscriber? Click here to view full article